Latest News by Industry
MADISON, Wis.--(BUSINESS WIRE)--Nov 1, 2024--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard ® and Oncotype ® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241101637242/en/
CONTACT: Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: ONCOLOGY HEALTH MEDICAL DEVICES HEALTH TECHNOLOGY OTHER HEALTH GENERAL HEALTH BIOTECHNOLOGY
SOURCE: Exact Sciences Corp.
Copyright Business Wire 2024.
PUB: 11/01/2024 06:00 AM/DISC: 11/01/2024 06:02 AM
http://www.businesswire.com/news/home/20241101637242/en